stella
beta
PD-1 Inhibitors Maintenance for cHL Post-autoHCT — Stella
Recruiting
Back to Hodgkin Lymphoma trials
Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations
(3 sites)
Kazakhstan
National Research Oncology Center, Astana
Russia
National Medical and Surgical Center named after N.I. Pirogov, Moscow
RM Gorbacheva Research Institute, Pavlov University, Saint Petersburg
View full record on ClinicalTrials.gov